143 related articles for article (PubMed ID: 30589039)
1. Safety and efficacy of transarterial interventional therapy for treatment of hepatocellular carcinoma with peritoneal metastases.
Duan F; Bai Y; Cui L; Li X; Yan J
J Cancer Res Ther; 2018; 14(7):1563-1566. PubMed ID: 30589039
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal metastases after transarterial embolization of hepatocellular carcinoma: An observational study.
Meier JM; Behr SC; Jordan E; Pallav Kolli K; Yeh BM
Abdom Radiol (NY); 2017 Jun; 42(6):1794-1798. PubMed ID: 28197682
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis.
Park MS; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Seong J
Cancer Chemother Pharmacol; 2013 Jan; 71(1):165-73. PubMed ID: 23079897
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Patients with Hepatocellular Carcinoma Treated with Conventional Transarterial Chemoembolization Using Guidance Software.
Miyayama S; Yamashiro M; Sugimori N; Ikeda R; Okimura K; Sakuragawa N
J Vasc Interv Radiol; 2019 Jan; 30(1):10-18. PubMed ID: 30580809
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis.
Lin CC; Liang HP; Lee HS; Huang GT; Yang PM; Ho MC; Lee PH; Tsang YM; Chen DS; Sheu JC; Chen CH
J Gastroenterol Hepatol; 2009 May; 24(5):815-20. PubMed ID: 19655437
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization of a colic branch of the superior mesenteric artery in patients with unresectable hepatocellular carcinoma.
Kim HC; Chung JW; An S; Seong NJ; Son KR; Jae HJ; Park JH
J Vasc Interv Radiol; 2011 Jan; 22(1):47-54. PubMed ID: 21195900
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience.
Idilman I; Peynircioğlu B; Cil BE; Doğanay Erdoğan B; Yalçın S; Bayraktar Y; Kav T; Altundağ K; Balkancı F
Turk J Gastroenterol; 2013; 24(2):141-7. PubMed ID: 23934461
[TBL] [Abstract][Full Text] [Related]
10. Clinical study of transarterial chemoembolization combined with 3-dimensional conformal radiotherapy for hepatocellular carcinoma.
Xu LT; Zhou ZH; Lin JH; Chen Z; Wang K; Wang P; Zhu XY; Shen YH; Meng ZQ; Liu LM
Eur J Surg Oncol; 2011 Mar; 37(3):245-51. PubMed ID: 21195578
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
[TBL] [Abstract][Full Text] [Related]
13. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma.
Shen J; Wang LF; Zou ZY; Kong WW; Yan J; Meng FY; Chen FJ; Du J; Shao J; Xu QP; Ren HZ; Li RT; Wei J; Qian XP; Liu BR
World J Gastroenterol; 2017 Aug; 23(29):5395-5404. PubMed ID: 28839440
[TBL] [Abstract][Full Text] [Related]
15. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
16. A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma.
Sebastian NT; Miller ED; Yang X; Diaz DA; Tan Y; Dowell J; Spain J; Rikabi A; Elliott E; Knopp M; Williams TM
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1276-1283. PubMed ID: 32712254
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
[TBL] [Abstract][Full Text] [Related]
18. Combined transarterial chemoembolization of the right inferior phrenic artery and radiofrequency ablation for small hepatocellular carcinoma near the diaphragm: its efficacy and safety.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Choo SW; Do YS
Abdom Radiol (NY); 2018 Oct; 43(10):2851-2858. PubMed ID: 29492603
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of HepaSphere 50-100 μm in the treatment of hepatocellular carcinoma.
Zurstrassen CE; Gireli LPO; Tyng CJ; Bitencourt AGV; Guimarães MD; Barbosa PNV; Santos Cavalcante ACB; Matushita Junior JP; Amoedo MK; Coimbra FJ; Alves RCP; Chojniak R
Minim Invasive Ther Allied Technol; 2017 Aug; 26(4):212-219. PubMed ID: 28635404
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial.
Yoon SM; Ryoo BY; Lee SJ; Kim JH; Shin JH; An JH; Lee HC; Lim YS
JAMA Oncol; 2018 May; 4(5):661-669. PubMed ID: 29543938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
